Lifeward

Lifeward EBITDA per Employee

The EBITDA per Employee of Lifeward (LFWD) as of Oct 9, 2026 is -398,612.24 USD. In the previous year, EBITDA per Employee was -399,040.82 USD — a change of -0.11% (higher).

EBITDA per Employee

-398,612.24USD

YoY

-0.11%

Last updated:

EBITDA per Employee of Lifeward is 2025 -398,612.24 USD. EBITDA per Employee of Lifeward was 2024 -399,040.82 USD. It decreases by -0.11% higher compared to the previous year.

The Lifeward EBITDA per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Employee
Date
EBITDA per Employee
Jan 1, 2018
-392,122.45 USD
Jan 1, 2019
-286,693.88 USD
Jan 1, 2020
-245,265.31 USD
Jan 1, 2021
-258,265.31 USD
Jan 1, 2022
-389,836.73 USD
Jan 1, 2023
-481,877.55 USD
Jan 1, 2024
-399,040.82 USD
Jan 1, 2025
-398,612.24 USD
The Lifeward EBITDA per Employee history
YEAREBITDA per EmployeeYoY
-398,612.24USD-0.11%
-399,040.82USD-17.19%
-481,877.55USD+23.61%
-389,836.73USD+50.94%
-258,265.31USD+5.30%
-245,265.31USD-14.45%
-286,693.88USD-26.89%
-392,122.45USD-12.63%
-448,816.33USD-27.76%
-621,244.90USD+20.92%
-513,755.10USD+26.34%
-406,632.65USD—
Access this data via the Eulerpool API

Lifeward Stock analysis

What does Lifeward do? Rewalk Robotics Ltd is a publicly traded company specializing in the development and manufacture of exoskeletons that enable individuals with spinal injuries or paralysis to regain mobility. It was founded in 2001 and is based in Marlborough, Massachusetts. The company's goal is to provide individuals with mobility impairments the opportunity for greater freedom of movement and improved quality of life. Rewalk Robotics has launched various products in the field of rehabilitation and industrial applications, and it continues to research and develop new applications for its technology. The exoskeletons use a combination of motors, sensors, and control systems to allow users to stand, walk, and even climb stairs. In addition to medical applications, Rewalk Robotics also provides exoskeletons for industrial use, enhancing worker safety and productivity. The company is actively involved in research and development to expand the therapeutic possibilities of exoskeletons for neurologic conditions such as stroke and Parkinson's disease. Rewalk Robotics is dedicated to innovation and technology, aiming to improve the lives of millions worldwide by providing greater mobility and autonomy. Lifeward is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Lifeward stock

EBITDA per Employee of Lifeward is -398,612.24 USD in 2025.

EBITDA per Employee of Lifeward changed from -399,040.82 USD to -398,612.24 USD, representing a -0.11% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Lifeward since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Lifeward historically and in real time.

Access this data via the Eulerpool API

Workforce — Lifeward

All Key Metrics — Lifeward